Counter statement to open letter to the Executive Director of the European Medicines Agency concerning the licensing of hydroxyethyl starch solutions for fluid resuscitation

Br J Anaesth. 2014 Jul;113(1):194-5. doi: 10.1093/bja/aeu217.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Fluid Therapy / standards*
  • Humans
  • Hydroxyethyl Starch Derivatives / standards*
  • Plasma Substitutes / standards*
  • Resuscitation / standards*

Substances

  • Hydroxyethyl Starch Derivatives
  • Plasma Substitutes